Follow The Filings

TK Teekay

Teekay earnings company data as of 1:01 PM ET 10/23

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 4 Nov EPS — — —
Rev — — —

Insider trades

Open-market buys and sales by TK's executives, directors and 10% owners in the last 12 months, from their Form 4s

All TK insider trades
  • None no insider bought on the open market
  • $7.5M sold by 4 insiders outside a trading plan
  • None no planned (10b5-1) sales
  1. Simon Heidi Locke Director
    Sale
    $5,972 400 shares at $14.93 0.9% of stake
    Traded Sep 17 Filed Sep 18
  2. Kenneth Hvid CEO
    Sale
    $1.9M 132,884 shares at $14.28 56% of stake
    Traded Sep 11 Filed Sep 11
  3. Simon Heidi Locke Director
    Sale
    $163K 11,585 shares at $14.08 20% of stake
    Traded Sep 10 Filed Sep 11
  4. Simon Heidi Locke Director
    Sale
    $21K 1,581 shares at $13.49 3.3% of stake
    Traded Aug 19–21 Filed Aug 21
  5. Brody Speers CFO
    Sale
    $31K 2,350 shares at $13.10 70% of stake
    Traded Aug 19 Filed Aug 19
  6. Rudolph Krediet Director
    Sale
    $475K 41,457 shares at $11.45 54% of stake
    Traded Aug 3 Filed Aug 3
  7. Simon Heidi Locke Director
    Sale
    $224K 18,119 shares at $12.37 28% of stake
    Traded Jun 22 Filed Jun 22
  8. Rudolph Krediet Director
    Sale
    $744K 63,042 shares at $11.80 64% of stake
    Traded Jun 17 Filed Jun 17
  9. Kenneth Hvid CEO
    Sale
    $82K 6,822 shares at $12.04 6.1% of stake
    Traded Jun 12 Filed Jun 12
  10. Kenneth Hvid CEO
    Sale
    $3.8M 315,335 shares at $12.11 74% of stake
    Traded Jun 11 Filed Jun 12
  11. Brody Speers CFO
    Sale
    $67K 5,500 shares at $12.15 62% of stake
    Traded Jun 11 Filed Jun 12

Also filed in the last 12 months, not counted as buying or selling: 10 option exercises, 3 stock grants, and 1 share withholding for taxes.

SEC filings

Recent issuer filings from EDGAR, 17 shown.

Filed Form Detail Links
6-K
6-K
SCHEDULE 13D/A —
6-K
6-K
20-F
6-K
SCHEDULE 13G/A —
6-K
SCHEDULE 13G —
6-K
6-K
6-K
6-K
20-F
SCHEDULE 13D/A —
6-K

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.